(2015–2051) Miscellaneous Rheumatic & Inflammatory Diseases Poster III

Tuesday, October 28, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

Baseline and 2-year Follow-up of Pulmonary Function Among CTD-ILD Subtypes
Abstract Poster Presenter: Anchal Sabharwal, MD – Northwell Health
10:30 AM - 12:30 PM Central Time

Behçet’s Syndrome Beyond Endemic Borders: A 24-Year Longitudinal Analysis of Mortality in a Diverse South American Cohort
Abstract Poster Presenter: Fabio Specian, Sr, MD – Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP)
10:30 AM - 12:30 PM Central Time

Can Colchicine Be a Therapeutic Option for Patients with Ankylosing Spondylitis?
Abstract Poster Presenter: Bahaddin Ates, n/a – Cerrahpasa Faculty of Medicine
10:30 AM - 12:30 PM Central Time

Characteristics of a Historical Cohort of Adult Patients with Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Francina Salabert Carreras, PhD – Hospital Germans Trias i Pujol
10:30 AM - 12:30 PM Central Time

Clinical Burden of Illness Among Patients with Immunoglobulin-G4-Related Disease in the United States
Abstract Poster Presenter: Sushmitha Inguva, PhD – Amgen Inc.
10:30 AM - 12:30 PM Central Time

Clinical Features and Treatment Outcomes in Aseptic Abscess Syndrome: A Systematic Review of 104 Cases
Abstract Poster Presenter: Eleni Papachristodoulou, MD – Mount Auburn Hospital, Harvard Medical School
10:30 AM - 12:30 PM Central Time

Clinical features of IgG4-related disease - a single centre experience
Abstract Poster Presenter: Alojzija Hocevar, MD, PhD – University Medical Center Ljubljana
10:30 AM - 12:30 PM Central Time

Clinical Predictors of Macrophage Activation Syndrome and Treatment Outcomes in Adult-Onset Still’s Disease: A 24-Year Single-Center Experience
Abstract Poster Presenter: Beste Acar, MD – Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa
10:30 AM - 12:30 PM Central Time

Complement Fragments are Deposited in the Submandibular Glands in IgG4-Related Disease
Abstract Poster Presenter: Guy Katz, MD – Massachusetts General Hospital
10:30 AM - 12:30 PM Central Time

DDR2 auto-phosphorylation in patients with Warburg-Cinotti syndrome promotes differentiation of fibroblasts into myofibroblasts and expansion of immature B cells with antibody production.
Abstract Poster Presenter: Sang Jin LEE, n/a – Kyungpook National University School of Medicine
10:30 AM - 12:30 PM Central Time

Descriptive Analysis of a Cohort of Neurosarcoidosis Mimics
Abstract Poster Presenter: Shivani Rangaswamy, MD – Duke University Hospital
10:30 AM - 12:30 PM Central Time

Effectiveness of Nintedanib combined with different DMARDs in joint and pulmonary domains of Rheumatoid Arthritis - Interstitial Lung Disease. National multicenter study of 74 patients
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
10:30 AM - 12:30 PM Central Time

Efficacy and Safety of Antifibrotic Therapy in Autoimmune–Associated Interstitial Lung Disease: A Meta-Analysis
Abstract Poster Presenter: Sri Laxmi Priya Sunkara, MD (she/her/hers) – White river medical center
10:30 AM - 12:30 PM Central Time

Evaluating Biologic Effectiveness in Co-Occurring Dermatologic and Rheumatic Disease: A Systematic Review
Abstract Poster Presenter: Nashwah Memon, BS – Lake Erie College of Osteopathic Medicine
10:30 AM - 12:30 PM Central Time

Hidden Burden in Rheumatology: Cross-Sectional Study of Hearing Loss in Systemic Autoimmune Diseases
Abstract Poster Presenter: Jairo Cajamarca, MD (he/him/his) – Fundacion universitaria de ciencia de la Salud
10:30 AM - 12:30 PM Central Time

Incidence of Coronavirus Disease 2019 in Participants with IgG4-Related Disease Treated with Inebilizumab in the MITIGATE Study
Abstract Poster Presenter: Arezou Khosroshahi, MD – Emory University
10:30 AM - 12:30 PM Central Time

Inebilizumab Efficacy and Safety in Patients with Common, Urgent, and Fibrotic Organ Manifestations of IgG4-RD: Subgroup Analyses from the MITIGATE Trial
Abstract Poster Presenter: Arezou Khosroshahi, MD – Emory University
10:30 AM - 12:30 PM Central Time

Infections and Associated Mortality in VEXAS Syndrome: A Systematic Review and Meta-Analysis
Abstract Poster Presenter: Ozlem Arikan, MD – Istanbul Aydin University
10:30 AM - 12:30 PM Central Time

Interim Phase 1 Results for SPY002, a Novel Half-Life Extended Monoclonal Antibody Targeting TL1A, Suggest A Potential for Q3M or Q6M Maintenance Dosing for Rheumatologic Disease
Abstract Poster Presenter: Joshua Friedman, MD, PhD – Spyre Therapeutics
10:30 AM - 12:30 PM Central Time

Investigating Epidemiology, Clinical associations, and Outcomes of Uveitis: A Retrospective Cohort Study
Abstract Poster Presenter: Archit Srivastava, MD, MBBS – Boston Medical Center-Brighton/South, Boston University
10:30 AM - 12:30 PM Central Time

Isolated Anti-Ro52 Antibody Positivity Is Associated with Increased Cancer Risk and Distinct Malignancy Patterns: A Retrospective Cohort Study from a Single Tertiary Center
Abstract Poster Presenter: CARMEN SECADA-GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA
10:30 AM - 12:30 PM Central Time

JAK1 selective inhibitors versus pan-JAK inhibitors: comparative real-world study of drug retention in chronic inflammatory arthritis
Abstract Poster Presenter: Leticia Leon, PhD, MSc (she/her/hers) – Hospital Clinico San Carlos
10:30 AM - 12:30 PM Central Time

Krebs von den Lungen 6 levels (∆KL6) is a reliable marker of disease activity and response to therapy in CTD-ILD
Abstract Poster Presenter: Fredeswinda Romero, MD (she/her/hers) – University Hospital Fundaci�n Jim�nez D�az\"\"
10:30 AM - 12:30 PM Central Time

Malignancy in Behçet’s Syndrome: A 24-Year Cohort Study In a Non-Endemicand Multiethnic Country
Abstract Poster Presenter: Pedro Cargnelutti de Araujo, Sr, MD – Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
10:30 AM - 12:30 PM Central Time

Management of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases: A Comparison of Rheumatologist and Pulmonologist Perspectives
Abstract Poster Presenter: Genna Braverman, MD, MS – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Racial Disparities in Outcomes Among Patients With Neuromyelitis Optica: A Global Population-Based Study
Abstract Poster Presenter: Chukwuemelie Okeke, MBBS – Maimonides Medical Center
10:30 AM - 12:30 PM Central Time

Real-World Use of Dual Targeted Therapy in Rheumatic Disease: A Single-Center Case Series
Abstract Poster Presenter: Marta Aguilar Zamora, MD (she/her/hers) – Hospital de Sagunto
10:30 AM - 12:30 PM Central Time

Renal Outcomes of Long-term Canakinumab in Patients with Adult Familial Mediterranean Fever (FMF) and Biopsy-Confirmed AA Amyloidosis
Abstract Poster Presenter: Omer Karadag, MD – Hacettepe University, Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine
10:30 AM - 12:30 PM Central Time

Safety and Effectiveness of the Use of Combined Therapy with bDMARDS and tsDMARDs in Immune-mediated Inflammatory Diseases
Abstract Poster Presenter: Natalia López Juanes, MD – Hospital Universitario La Paz
10:30 AM - 12:30 PM Central Time

Spectrum of Autoantibodies in CNS Demyelinating Diseases: Clinical, Laboratory and Imaging Associations
Abstract Poster Presenter: Clio Mavragani, MD – National and Kapodistrian University of Athens
10:30 AM - 12:30 PM Central Time

Steroid Psychosis and Neuropsychiatric Symptoms induced by Corticosteroid Injection in Rheumatology Patients
Abstract Poster Presenter: Morvarid Kavosh, MD – University of New Mexico
10:30 AM - 12:30 PM Central Time

The Largest International Cohort Study of HA20 Reveals Novel Genetic Architecture and Age-Dependent Phenotypic Evolution
Abstract Poster Presenter: Manuel Carpio Tumba, MD – University of Pittsburgh
10:30 AM - 12:30 PM Central Time

To Hold or Not to Hold: Variability in Management of DMARDs in the Setting of Acute Infections - A Survey of Rheumatologists
Abstract Poster Presenter: Mollie Gellman, MD – Montefiore Medical Center
10:30 AM - 12:30 PM Central Time

Trends in Lung Transplant Listing Outcomes in Connective Tissue Disease associated Interstitial Lung Disease (CTD-ILD) Across Two Decades
Abstract Poster Presenter: Sambhawana Bhandari, MD – Washington University in St Louis
10:30 AM - 12:30 PM Central Time

Utilization of the All of Us Research Program to Study the Impact of Genetic Background on Autoinflammatory Diseases
Abstract Poster Presenter: Qingping Yao, MD, PhD – Stony Brook University
10:30 AM - 12:30 PM Central Time

Validation of systemic Juvenile Arthritis Disease Activity Score 10 (sJADAS 10) in adult patients with Still’s Disease
Abstract Poster Presenter: Georgia-Savina Moysidou, MD, PhD – AP-HP